Pricing Log in Create free account

Addex Therapeutics Ltd. Sponsored ADR (ADXN) vs Aptevo Therapeutics Inc. (APVO)

Addex Therapeutics Ltd. Sponsored ADR and Aptevo Therapeutics Inc. are both Biotechnology companies. Addex Therapeutics Ltd. Sponsored ADR and Aptevo Therapeutics Inc. are of similar size ($3.2M and $3.1M). Addex Therapeutics Ltd. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against −89.4%. Across the 14 metrics below, Aptevo Therapeutics Inc. leads on 9 and Addex Therapeutics Ltd. Sponsored ADR on 5.

Valuation

Metric ADXN APVO Biotechnology median
P/E n/m 0.00 8.50
P/S 27.97 0.15 9.71
P/B 1.17 0.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.17 0.64
EV/Sales 18.34 (0.34) 9.21
Earnings yield (318.34%) 100,773.33% (33.15%)
Free cash flow yield (104.65%) (1,315.16%) (25.50%)

Profitability

Metric ADXN APVO Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.91%) (446.89%) (56.36%)
Return on assets (117.46%) (186.29%) (48.04%)
Return on invested capital (141.24%) 0.00% 0.00%

Growth

Metric ADXN APVO Biotechnology median
Revenue growth (TTM) (89.37%) 92.94% 6.02%
EPS growth (last fiscal year) (191.09%) 99.72% 30.26%
Revenue growth, 5-year CAGR (60.68%) (26.64%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADXN APVO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.76 2.08 4.72
Net debt to EBITDA 0.58 0.83 0.96

Dividend

Metric ADXN APVO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADXN APVO Biotechnology median
Market cap 3.20m 3.08m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack